Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: The role of mitochondrial permeability transition

Anesthesia and Analgesia

Volumn 107, Issue 3, 2008, Pages 769-775

  Pagel, Paul S ^a   Krolikowski, John G ^a   Pratt Jr , Phillip F ^a   Shim, Yon Hee ^a   Amour, Julien ^a   Warltier, David C ^a   Weihrauch, Dorothee ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ATRACTYLOSIDE; GLYCOGEN SYNTHASE KINASE 3BETA; HELIUM; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; OXYGEN; PIFITHRIN ALPHA; PROTEIN P53; SODIUM CHLORIDE; BENZOTHIAZOLE DERIVATIVE; CARDIOTONIC AGENT; DRUG DERIVATIVE; GLYCOGEN SYNTHASE KINASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; PIFITHRIN; TOLUENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EXPERIMENTAL RABBIT; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEMODYNAMIC MONITORING; HYPOTHESIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MITOCHONDRIAL PERMEABILITY; NONHUMAN; OXYGEN CONCENTRATION; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; MITOCHONDRION; PERMEABILITY; RABBIT;

ANIMALS; APOPTOSIS; ATRACTYLOSIDE; BENZOTHIAZOLES; CARDIOTONIC AGENTS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HELIUM; INDOLES; MALE; MALEIMIDES; MITOCHONDRIA; OXYGEN; PERMEABILITY; RABBITS; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 51449098817     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181815b84     Document Type: Article

References (32)

1. Pagel PS, Krolikowski JG, Venkatapuram S, Shim YH, Kersten JR, Weihrauch D, Warltier DC, Pratt PF Jr. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 2007;105:562-9
2. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006;105: 187-97
3. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001;359:1-6
4. Eldar-Finkelman H, Schreyer SA, Shinohara MM, LeBoeuf RC, Krebs EG. Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 1999;48: 1662-6
5. Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP. The active form of glycogen synthase kinase-3- is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathol 2002;103:91-9
6. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3- during preconditioning through phosphatidylinositol-3-kinase- dependent pathway is cardioprotective. Circ Res 2002;90:377-9
7. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase - inhibition during reperfusion in intact rat hearts. Circ Res 2004;94:960-6
8. Gross ER, Hsu AK, Gross GJ. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3beta. Am J Physiol Heart Circ Physiol 2006;291:H827-H34
9. Gross ER, Hsu AK, Gross GJ. GSK3- inhibition and KATP channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol 2007;102:341-9
10. Park SS, Zhao H, Jang Y, Mueller RA, Xu Z. N6-(3-iodobenzyl)- adenosine-5--N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J Pharmacol Exp Ther 2006;318:124-31
11. Hunter JC, Kostyak JC, Novotny JL, Simpson AM, Korzick DH. Estrogen deficiency decreases ischemic tolerance in the aged rat heart: roles of PKCdelta, PKCepsilon, Akt, and GSK3beta. Am J Physiol Regul Integr Comp Physiol 2007;292:R800-R9
12. Pagel PS, Krolikowski JG, Neff DA, Weihrauch D, Bienengraeber M, Kersten JR, Warltier DC. Inhibition of glycogen synthase kinase potentiates isoflurane-induced protection against myocardial infarction during early reperfusion in vivo. Anesth Analg 2006;102:1348-54
13. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ. Glycogen sythase kinase-3- mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004;113:1535-49
14. Watcharasti P, Bijur GN, Song L, Zhu J, Chen X, Jope RS. Glycogen synthase kinase-3- (GSK3-) binds to and promotes the actions of p53. J Biol Chem 2003;278:48872-9
15. Chipuk JE, Kuwana T, Bouchier-Hayes L, DroinNM,NewmeyerDD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004;303:1010-4
16. Mocanu MM, Yellon DM. p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning. FEBS Lett 2003;555:302-6
17. Tomasevic G, Shamloo M, Israeli D, Wieloch T. Activation of p53 and its target genes p21WAF1/Cip1 and PAG608/Wig-1 in ischemic preconditioning. Brain Res Mol Brain Res 1999;70: 304-13
18. Venkatapuram S, Wang C, Krolikowski JG, Weihrauch D, Kersten JR, Warltier DC, Pratt PF Jr, Pagel PS. Inhibition of apoptotic protein p53 lowers the threshold of isofluraneinduced cardioprotection during early reperfusion in rabbits. Anesth Analg 2006;103:1400-5
19. Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR, Pagel PS. Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: role of mitochondrial KATP channels. Anesth Analg 2005;101:1590-6
20. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Waritier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005;102:102-9
21. Feng J, Fischer G, Lucchinetti E, Zhu M, Bestman L, Jegger D, Arras M, Pasch T, Perriard JC, Schaub MC, Zaugg M. Infarctremodeled myocardium is receptive to protection by isoflurane postconditioning. Role of protein kinase B/Akt signaling. Anesthesiology 2006;104:1004-14
22. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase-3-. Anesthesiology 2005;103:987-95
23. Vousden KH. Activation of the p53 tumor suppressor protein. Biochem Biophys Acta 2002;1602:47-59
24. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003;11:577-90
25. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604
26. Maulik N, Sasaki N, Addya S, Das DK. Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors. FEBS Lett 2000;485:7-12
27. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S, Tsutsui H. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res 2006;70:457-65
28. Ashcroft M, Ludwig RL, Woods DB, Copeland TD, Weber HO, MacRae EJ, Vousden KH. Phosphorylation of HDM2 by Akt. Oncogene 2002;21:1955-62
29. Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K, Masuyama N, Gotoh Y. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 2002;277: 21843-50
30. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudhov AV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285:1733-7
31. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC. Selective small molecular inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 2000;7:793-803
32. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 2004;61:372-85